Cross-regulation between protein L-isoaspartyl O-methyltransferase and ERK in epithelial mesenchymal transition of MDA-MB-231 cells

Acta Pharmacologica Sinica

Volumn 32, Issue 9, 2011, Pages 1165-1172

  Ryu, Jiyeon ^a   Song, Jihyeok ^a   Heo, Jieun ^a   Jung, Yongwoo ^a   Lee, Sang Jin ^a   Hong, Sungyoul ^a   Cho, Jae Youl ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

breast cancer; epithelial mesenchymal transition; extracellular signal regulated kinase (ERK); metastasis; protein L isoaspartyl O methyltransferase (PIMT); si RNA

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CD51 ANTIGEN; GELATINASE A; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN L ISOASPARTYL O METHYLTRANSFERASE; PROTEIN METHYLTRANSFERASE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL ADHESION; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MESENCHYME CELL; METASTASIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; ORGANIC CATION TRANSPORT PROTEINS; PROTEIN D-ASPARTATE-L-ISOASPARTATE METHYLTRANSFERASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80052463000     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2011.94     Document Type: Article

References (45)

1. Creighton CJ, Chang JC, Rosen JM. Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer. J Mammary Gland Biol Neoplasia 2010; 15: 253-60
2. Yang J, Weinberg RA. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 2008 14: 818-29 (Pubitemid 351757205)
3. Do Kwon Y, Bin Noh H, Ahn HJ, Lee WJ, Kwack K. The molecular signature of in vitro senescence in human mesenchymal stem cells Genes Genom 2010; 32: 87-93
4. Gotzmann J, Mikula M, Eger A, Schulte-Hermann R, Foisner R, Beug H, et al. Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis. Mutat Res 2004; 566: 9-20 (Pubitemid 38045586)
5. Smalley KS, Brafford PA, Herlyn M. Selective evolutionary pressure from the tissue microenvironment drives tumor progression. Semin Cancer Biol 2005; 15: 451-9. (Pubitemid 41318045)
6. Shimizu T, Matsuoka Y, Shirasawa T. Biological significance of soaspartate and its repair system. Biol Pharm Bull 2005; 28 1590-6 (Pubitemid 41324114)
7. Reissner KJ, Aswad DW. Deamidation and isoaspartate formation in proteins: unwanted alterations or surreptitious signals? Cell Mol Life Sci 2003; 60: 1281-95. (Pubitemid 36900513)
8. Lanthier J, Desrosiers RR. Protein L-isoaspartyl methyltransferase repairs abnormal aspartyl residues accumulated in vivo in type-collagen and restores cell migration. Exp Cell Res 2004; 293 96-105 (Pubitemid 38064417)
9. Lanthier J, Desrosiers RR. Regulation of protein L-isoaspartyl methyl-transferase by cell-matrix interactions: involvement of integrin alphavbeta3, PI3-kinase, and the proteasome. Biochem Cell Bio 2006; 84: 684-94 (Pubitemid 46121592)
10. Johnson-Holiday C, Singh R, Johnson E, Singh S, Stockard CR, Grizzle WE, et al. CCL25 mediates migration, invasion and matrix metallo-proteinase expression by breast cancer cells in a CCR9-dependent fashion. Int J Oncol 2011; 38: 1279-85
11. Garrido T, Riese HH, Aracil M, Perez-Aranda A. Endothelial cel differentiation into capillary-like structures in response to tumour cel conditioned medium: a modified chemotaxis chamber assay Br J Cancer 1995; 71: 770-5
12. Hunakova L, Sedlakova O, Cholujova D, Gronesova P, Duraj J, Sedlak J Modulation of markers associated with aggressive phenotype in MDA-MB-231 breast carcinoma cells by sulforaphane. Neoplasma 2009; 56: 548-56
13. Cho JY, Fox DA, Horejsi V, Sagawa K, Skubitz KM, Katz DR, et al. The functional interactions between CD98, beta1-integrins, and CD147 in the induction of U937 homotypic aggregation. Blood 2001; 98 374-82
14. Rhee DK, Kim EH, Lee MJ, Kim IH, Pyo S, Choi KT. Anti-apoptotic effects of red ginseng on oxidative stress induced by hydrogen per-oxide in SK-N-SH cells. J Ginseng Res 2010; 34: 138-44
15. Lee YH, Hong JK, Kim JS, Kim JA, Lee SI, Lim MH, et al. Identifcation and characterization of SHI family genes from Brassica rapa L ssp pekinensis. Genes Genom 2010; 32: 309-17
16. Xing P, Li JG, Jin F, Zhao TT, Liu Q, Dong HT, et al. Fascin, an actin-bundling protein, promotes breast cancer progression in vitro. Cel Biochem Funct 2011; 29: 303-10
17. Park JK, Do Kim H, Ha SE, Kang JR. Effect of Korean red ginseng extract on cell death responses in peroxynitrite-treated keratinocytes J Ginseng Res 2010; 34: 205-11.
18. Tsuchiyama J, Imajo K, Yoshino T, Nanba N, Toyota A, Yoshida C, et al. High-dose chemotherapy and autologous peripheral blood stem cell transplantation for treatment of unspecified peripheral T-cel lymphoma presented with hepatosplenomegaly and hypercytokinemia syndrome: report of three cases. Ann Hematol 2002; 81: 588-92 (Pubitemid 36097045)
19. Chun YJ, Shim JH, Choi CS, Lee EC Kim MY. Tamoxifen suppresses clusterin level through Akt inactivation and proteasome degradation in human prostate cancer cells. Biomol Ther 2009; 17: 25-31.
20. Chun YJ, Lee HM, Surh BY. Roles of neutral sphingomyelinase 1 on CD95-mediated apoptosis in human Jurkat T lymphocytes. Biomo Ther 2010; 18: 262-70
21. Gottschall PE, Yu X. Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes. J Neuro-chem 1995; 64: 1513-20.
22. Moon A, Kim JS. Fibronectin induces Pro-MMP-2 activation and enhances invasion in H-Ras-transformed human breast epithelia cells. Biomol Ther 2009; 17: 288-92
23. Nobes CD, Hall A. Rho GTPases control polarity protrusion, and adhesion during cell movement. J Cell Biol 1999; 144: 1235-44 (Pubitemid 29157301)
24. Kang TJ, Lee GS, Choi JY, Choi YJ, Yim DS, Cheong JH. The wound healing effect of Hydnocarpi Semen extract on ulcer in diabetic mice Biomol Ther 2010; 18: 329-35
25. Haraguchi M, Okubo T, Miyashita Y, Miyamoto Y, Hayashi M, Crotti TN, et al. Snail regulates cell-matrix adhesion by regulation of the expression of integrins and basement membrane proteins. J Bio Chem 2008; 283: 23514-23
26. Larriba MJ, Martin-Villar E, Garcia JM, Pereira F, Pena C, de Herreros AG, et al. Snail2 cooperates with Snail1 in the repression of vitamin D receptor in colon cancer. Carcinogenesis 2009; 30: 1459-68
27. Lamarre M, Desrosiers RR. Up-regulation of protein L-isoaspartyl methyltransferase expression by lithium is mediated by glycogen synthase kinase-3 inactivation and beta-catenin stabilization. Neuro-pharmacology 2008; 55: 669-76
28. Arima Y, Inoue Y, Shibata T, Hayashi H, Nagano O, Saya H, et al. Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition. Cancer Res 2008; 68: 5104-12
29. Kim JB, Yu JH, Ko E, Lee KW, Song AK, Park SY, et al. The alkaloid berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest. Phyto-medicine 2010; 17: 436-40
30. Savagner P. The epithelial-mesenchymal transition (EMT) pheno-menon. Ann Oncol 2010; 21: vii89-vii92
31. Thiery JP. Epithelial-mesenchymal transitions in tumour progression Nat Rev Cancer 2002; 2: 442-54
32. Manes T, Zheng DQ, Tognin S, Woodard AS, Marchisio PC, Languino LR. Alpha(v)beta3 integrin expression up-regulates cdc2, which modulates cell migration. J Cell Biol 2003; 161: 817-26 (Pubitemid 36648764)
33. Chou TY, Chen WC, Lee AC, Hung SM, Shih NY Chen MY. Clusterin silencing in human lung adenocarcinoma cells induces a mesen-chymal-to-epithelial transition through modulating the ERK/Slug path-way. Cell Signal 2009; 21: 704-11.
34. Kuo PL, Chen YH, Chen TC, Shen KH, Hsu YL. CXCL5/ENA78 ncreased cell migration and epithelial-to-mesenchymal transition of hormone-independent prostate cancer by early growth response-1/ Snail signaling pathway J Cell Physiol 2010; 226: 1224-31
35. Gollob JA, Wilhelm S, Carter C, Kelley SL. Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signa trans duction pathway Semin Oncol 2006; 33: 392-406 (Pubitemid 44142735)
36. Cho JY, Skubitz KM, Katz DR, Chain BM. CD98-dependent homotypic aggregation is associated with translocation of protein kinase Cdelta and activation of mitogen-activated protein kinases. Exp Cell Res 2003; 286: 1-11. (Pubitemid 36506853)
37. Stahle M, Veit C, Bachfscher U, Schierling K, Skripczynski B, Hall A, et al. Mechanisms in LPA-induced tumor cell migration: critical role of phosphorylated ERK. J Cell Sci 2003; 116: 3835-46 (Pubitemid 37185312)
38. Gal A, Sjoblom T, Fedorova L, Imreh S, Beug H, Moustakas A Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis. Oncogene 2008; 27: 1218-30. (Pubitemid 351294691)
39. Huebscher KJ, Lee J, Rovelli G, Ludin B, Matus A, Stauffer D, et al. Protein isoaspartyl methyltransferase protects from Bax-induced apoptosis. Gene 1999; 240: 333-41
40. Furuchi T, Sakurako K, Katane M, Sekine M, Homma H. The role of protein L-isoaspartyl/D-aspartyl O-methyltransferase (PIMT) in ntracellular signal transduction. Chem Biodivers 2010; 7: 1337-48
41. Cournoyer P, Desrosiers RR. Valproic acid enhances protein L-iso-aspartyl methyltransferase expression by stimulating extracellular signal-regulated kinase signaling pathway Neuropharmacology 2009 56: 839-48
42. Alison MR, Lim SM, Nicholson LJ. Cancer stem cells: problems for therapy? J Pathol 2011; 223: 147-61.
43. Kong D, Banerjee S, Ahmad A, Li Y, Wang Z, Sethi S, et al. Epithelia to mesenchymal transition is mechanistically linked with stem cel signatures in prostate cancer cells. PLoS One 2010; 5: e12445
44. Kondo M, Wagers AJ, Manz MG, Prohaska SS, Scherer DC Beilhack GF, et al. Biology of hematopoietic stem cells and progenitors mplications for clinical application. Annu Rev Immunol 2003; 21: 759-806 (Pubitemid 37174547)
45. +/CD24- phenotype. BMC Cancer 2010; 10: 411.